Yolanda D Tseng, MD

Research interests: radiation oncology interfacing with palliative care, disease site specific interest in lymphomas overlap with rad onc and/or palliative care

Dr. Tseng is a radiation oncologist and associate professor at the University of Washington and a joint associate professor at the Fred Hutch Cancer Research Center (Seattle, Washington). Dr. Tseng received her medical degree from Harvard Medical School and graduated residency from the Harvard Radiation Oncology Program. She has also completed a summer program in clinical effectiveness at the Harvard School of Public Health in Boston.

Her clinical practice focuses on patients with hematologic malignancies and central nervous system tumors, in addition to advanced cancer patients requiring palliative radiotherapy.

As a clinical researcher in lymphoma and palliative radiotherapy, her primary focus is on questions that inform therapeutic decisions in daily clinical practice. These include: 1) using advanced treatment techniques and treatment algorithms to widen the therapeutic ratio for late effects in lymphoma patients, 2) evaluating how patient characteristics and tumor subtypes affect responses to radiotherapy, and 3) understanding clinical decision-making and workflows in palliative radiotherapy and use of radiation at the end of life.

She is the palliative care track Vice Chair for the ASTRO Annual Meeting Scientific Committee and a member of the Society for Palliative Radiation Oncology executive committee, International Lymphoma Research Oncology Group (ILROG) educational steering committee, and the Chair of the Proton Collaborative Group (PCG) lymphoma committee.

Editorial Board
Terms of Appointment: May 2019 - April 2021;  February 2022 - January 2024